I understand the active period difference but the trial process is comparative. OSL is a bit undervalued no question.
Something no-one has commented on in this space is that neither product are a cure but merely an abstaining of the inevitable. Crappy thing to say I admit but it doesn't address the problem it just decelerates its continued growth. The upside is in-situ radiotherapy in itself is an awesome step forward as current practise has awful side effects and collateral damage.
Cheers.
OSL Price at posting:
8.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)